Abstract
We present a bipartite graph-based approach to calculate drug pairwise similarity for identifying potential new indications of approved drugs. Both chemical and molecular features were used in drug similarity calculation. In this paper, we first extracted drug chemical structures and drug-target interactions. Second, we computed chemical structure similarity and drug- target profile similarity. Further, we constructed a bipartite graph model with known relationships between drugs and their target proteins. Finally, we weighted summing drug structure similarity with target profile similarity to derive drug pairwise similarity, so that we can predict potential indication of a drug from its similar drugs. In addition, we summarized some alternative strategies and variations follow-up to each section in the overall analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Walters WP, Green J, Weiss JR, Murcko MA (2011) What do medicinal chemists actually make? A 50-year retrospective. J Med Chem 54(19):6405–6416
Hurle MR, Yang L, Xie Q, Rajpal DK, Sanseau P, Agarwal P (2013) Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther 93(4):335–341
Dickson M, Gagnon JP (2004) The cost of new drug discovery and development. Discov Med 4(22):172–179
Bolgár B, Arany Á, Temesi G, Balogh B, Antal P, Mátyus P (2013) Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies. Curr Top Med Chem 13(18):2337–2363
Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB (2009) Predicting new molecular targets for known drugs. Nature 462(7270):175–181
Von EJ, Murgueitio MS, Dunkel M, Koerner S, Bourne PE, Preissner R (2011) PROMISCUOUS: a database for network-based drug-repositioning. Nucleic Acids Res 39(Database issue):D1060
Chong CR, Sullivan DJ (2007) New uses for old drugs. Nature 448(7154):645–646
Liu Z, Fang H, Reagan K, Xu X, Mendrick DL, Jr WS, Tong W (2013) In silico drug repositioning–what we need to know. Drug Discov Today 18(3–4):110–115
Oprea TI, Mestres J (2012) Drug repurposing: far beyond new targets for old drugs. AAPS J 14(4):759–763
Jin G, Wong STC (2014) Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today 19(5):637–644
Cheng FX, Zhao ZM (2014) Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. J Am Med Inform Assoc 21(E2):E278–E286. https://doi.org/10.1136/amiajnl-2013-002512
Brown AS, Patel CJ (2017) MeSHDD: literature-based drug-drug similarity for drug repositioning. J Am Med Inform Assoc 24(3):614–618. https://doi.org/10.1093/jamia/ocw142
Udrescu L, Sbarcea L, Topirceanu A, Iovanovici A, Kurunczi L, Bogdan P, Udrescu M (2016) Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing. Sci Rep 6:32745. https://doi.org/10.1038/srep32745
Vilar S, Hripcsak G (2017) The role of drug profiles as similarity metrics: applications to repurposing, adverse effects detection and drug-drug interactions. Brief Bioinform 18(4):670–681. https://doi.org/10.1093/bib/bbw048
Ye H, Liu Q, Wei J (2014) Construction of drug network based on side effects and its application for drug repositioning. PLoS One 9(2):e87864. https://doi.org/10.1371/journal.pone.0087864
Huang H, Nguyen T, Ibrahim S, Shantharam S, Yue Z, Chen JY (2015) DMAP: a connectivity map database to enable identification of novel drug repositioning candidates. BMC Bioinformatics 16(Suppl 13):S4. https://doi.org/10.1186/1471-2105-16-S13-S4
Wen M, Zhang ZM, Niu SY, Sha HZ, Yang RH, Yun YH, Lu HM (2017) Deep-learning-based drug-target interaction prediction. J Proteome Res 16(4):1401–1409. https://doi.org/10.1021/acs.jproteome.6b00618
Huang LC, Soysal E, Zheng W, Zhao Z, Xu H, Sun J (2015) A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case. BMC Syst Biol 9(Suppl 4):S2. https://doi.org/10.1186/1752-0509-9-S4-S2
Le DH, Nguyen-Ngoc D (2018) Drug repositioning by integrating known disease-gene and drug-target associations in a semi-supervised learning model. Acta Biotheor. https://doi.org/10.1007/s10441-018-9325-z
Luo Y, Zhao X, Zhou J, Yang J, Zhang Y, Kuang W, Peng J, Chen L, Zeng J (2017) A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nat Commun 8(1):573. https://doi.org/10.1038/s41467-017-00680-8
Li L, He X, Borgwardt K (2018) Multi-target drug repositioning by bipartite block-wise sparse multi-task learning. BMC Syst Biol 12(Suppl 4):55. https://doi.org/10.1186/s12918-018-0569-7
Lu L, Yu H (2018) DR2DI: a powerful computational tool for predicting novel drug-disease associations. J Comput Aided Mol Des 32(5):633–642. https://doi.org/10.1007/s10822-018-0117-y
Wu G, Liu J, Wang C (2017) Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration. BMC Med Genet 10(Suppl 5):79. https://doi.org/10.1186/s12920-017-0311-0
Liang X, Zhang P, Yan L, Fu Y, Peng F, Qu L, Shao M, Chen Y, Chen Z (2017) LRSSL: predict and interpret drug-disease associations based on data integration using sparse subspace learning. Bioinformatics 33(8):1187–1196. https://doi.org/10.1093/bioinformatics/btw770
Zhang P, Wang F, Hu J (2014) Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity. AMIA Annu Symp Proc 2014:1258–1267
Chen H, Zhang Z (2015) A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning. Biomed Res Int 2015:406463. https://doi.org/10.1155/2015/406463
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074–D1082. https://doi.org/10.1093/nar/gkx1037
Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45(D1):D353–D361. https://doi.org/10.1093/nar/gkw1092
Hecker N, Ahmed J, von Eichborn J, Dunkel M, Macha K, Eckert A, Gilson MK, Bourne PE, Preissner R (2012) SuperTarget goes quantitative: update on drug-target interactions. Nucleic Acids Res 40(Database issue):D1113–D1117. https://doi.org/10.1093/nar/gkr912
Davis AP, King BL, Mockus S, Murphy CG, Saraceni-Richards C, Rosenstein M, Wiegers T, Mattingly CJ (2011) The comparative toxicogenomics database: update 2011. Nucleic Acids Res 39(Database):D1067–D1072. https://doi.org/10.1093/nar/gkq813
Barbarino JM, Whirl-Carrillo M, Altman RB, Klein TE (2018) PharmGKB: a worldwide resource for pharmacogenomic information. Wiley Interdiscip Rev Syst Biol Med 10(4):e1417. https://doi.org/10.1002/wsbm.1417
Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S (2017) Protein data bank (PDB): the single global macromolecular structure archive. Methods Mol Biol 1607:627–641. https://doi.org/10.1007/978-1-4939-7000-1_26
Leaman R, Wei CH, Lu Z (2015) tmChem: a high performance approach for chemical named entity recognition and normalization. J Cheminform 7(Suppl 1 Text mining for chemistry and the CHEMDNER track):S3. https://doi.org/10.1186/1758-2946-7-S1-S3
Li YH, Yu CY, Li XX, Zhang P, Tang J, Yang Q, Fu T, Zhang X, Cui X, Tu G, Zhang Y, Li S, Yang F, Sun Q, Qin C, Zeng X, Chen Z, Chen YZ, Zhu F (2018) Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Res 46(D1):D1121–D1127. https://doi.org/10.1093/nar/gkx1076
Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A (2015) OMIM.org: online Mendelian inheritance in man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res 43(Database issue):D789–D798. https://doi.org/10.1093/nar/gku1205
Bodenreider O (2004) The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res 32(Database issue):D267–D270. https://doi.org/10.1093/nar/gkh061
UniProt Consortium T (2018) UniProt: the universal protein knowledgebase. Nucleic Acids Res 46(5):2699. https://doi.org/10.1093/nar/gky092
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, von Mering C (2015) STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43(Database issue):D447–D452. https://doi.org/10.1093/nar/gku1003
Rogers DJ, Tanimoto TT (1960) A computer program for classifying plants. Science 132(3434):1115–1118. https://doi.org/10.1126/science.132.3434.1115
Liu X, Zhu F, Ma XH, Shi Z, Yang SY, Wei YQ, Chen YZ (2013) Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery. Curr Med Chem 20(13):1646–1661
Bolton EE, Kim S, Bryant SH (2011) PubChem3D: similar conformers. J Cheminform 3:13. https://doi.org/10.1186/1758-2946-3-13
Kim S, Bolton EE, Bryant SH (2016) Similar compounds versus similar conformers: complementarity between PubChem 2-D and 3-D neighboring sets. J Cheminform 8:62. https://doi.org/10.1186/s13321-016-0163-1
Hattori M, Okuno Y, Goto S, Kanehisa M (2003) Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. J Am Chem Soc 125(39):11853–11865. https://doi.org/10.1021/ja036030u
King MD, Long T, Pfalmer DL, Andersen TL, McDougal OM (2018) SPIDR: small-molecule peptide-influenced drug repurposing. BMC Bioinformatics 19(1):138. https://doi.org/10.1186/s12859-018-2153-y
Skinnider MA, Dejong CA, Franczak BC, McNicholas PD, Magarvey NA (2017) Comparative analysis of chemical similarity methods for modular natural products with a hypothetical structure enumeration algorithm. J Cheminform 9(1):46. https://doi.org/10.1186/s13321-017-0234-y
Lima AN, Philot EA, Trossini GHG, Scott LPB, Maltarollo VG, Honorio KM (2016) Use of machine learning approaches for novel drug discovery. Expert Opin Drug Discov 11(3):225–239. https://doi.org/10.1517/17460441.2016.1146250
DeSantis TZ, Keller K, Karaoz U, Alekseyenko AV, Singh NN, Brodie EL, Pei Z, Andersen GL, Larsen N (2011) Simrank: rapid and sensitive general-purpose k-mer search tool. BMC Ecol 11:11. https://doi.org/10.1186/1472-6785-11-11
Smith TF, Waterman MS (1981) Identification of common molecular subsequences. J Mol Biol 147(1):195–197
Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M (2008) Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24(13):i232–i240. https://doi.org/10.1093/bioinformatics/btn162
Yildirim MA, Goh KI, Cusick ME, Barabasi AL, Vidal M (2007) Drug-target network. Nat Biotechnol 25(10):1119–1126. https://doi.org/10.1038/nbt1338
Phatak SS, Zhang S (2013) A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors. Pac Symp Biocomput:29–40
Acknowledgments
This work was supported by the National Natural Science Foundation of China (Grant No. 81601573), the National Key Research and Development Program of China (Grant No. 2016YFC0901901), the Key Laboratory of Medical Information Intelligent Technology Chinese Academy of Medical Sciences, the National Population and Health Scientific Data Sharing Program of China, and the Knowledge Centre for Engineering Sciences and Technology (Medical Centre).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zheng, S., Ma, H., Wang, J., Li, J. (2019). A Computational Bipartite Graph-Based Drug Repurposing Method. In: Vanhaelen, Q. (eds) Computational Methods for Drug Repurposing. Methods in Molecular Biology, vol 1903. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8955-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8955-3_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8954-6
Online ISBN: 978-1-4939-8955-3
eBook Packages: Springer Protocols